🚀 VC round data is live in beta, check it out!
Gerresheimer Overview
About Gerresheimer
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Founded
1864
HQ
Employees
12.1K
Website
Sectors
Financials (LTM)
EV
$3B
Gerresheimer Financials
Gerresheimer reported last 12-month revenue of $3B and EBITDA of $483M.
In the same LTM period, Gerresheimer generated $682M in gross profit, $483M in EBITDA, and $5M in net income.
Revenue (LTM)
Gerresheimer P&L
In the most recent fiscal year, Gerresheimer reported revenue of $2B and EBITDA of $469M.
Gerresheimer expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $682M | XXX | $703M | XXX | XXX | XXX |
| Gross Margin | 25% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $483M | XXX | $469M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $5M | XXX | $127M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Gerresheimer Stock Performance
Gerresheimer has current market cap of $644M, and enterprise value of $3B.
Market Cap Evolution
Gerresheimer's stock price is $18.64.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $644M | -0.5% | XXX | XXX | XXX | $3.67 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGerresheimer Valuation Multiples
Gerresheimer trades at 1.1x EV/Revenue multiple, and 6.1x EV/EBITDA.
EV / Revenue (LTM)
Gerresheimer Financial Valuation Multiples
As of March 28, 2026, Gerresheimer has market cap of $644M and EV of $3B.
Equity research analysts estimate Gerresheimer's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Gerresheimer has a P/E ratio of 136.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $644M | XXX | $644M | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 6.1x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBIT | 16.8x | XXX | 10.9x | XXX | XXX | XXX |
| EV/Gross Profit | 4.3x | XXX | 4.2x | XXX | XXX | XXX |
| P/E | 136.4x | XXX | 5.1x | XXX | XXX | XXX |
| EV/FCF | (43.4x) | XXX | (19.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Gerresheimer Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Gerresheimer Margins & Growth Rates
Gerresheimer's revenue in the last 12 month grew by 2%.
Gerresheimer's revenue per employee in the last FY averaged $0.2M.
Gerresheimer's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Gerresheimer's rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Gerresheimer Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | — | XXX | XXX | XXX |
| G&A Expenses to Revenue | 0% | XXX | 17% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Gerresheimer Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Salus | XXX | XXX | XXX | XXX | XXX | XXX |
| Embecta | XXX | XXX | XXX | XXX | XXX | XXX |
| Arjo | XXX | XXX | XXX | XXX | XXX | XXX |
| Cerus | XXX | XXX | XXX | XXX | XXX | XXX |
| Paul Hartmann | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Gerresheimer M&A Activity
Gerresheimer acquired XXX companies to date.
Last acquisition by Gerresheimer was on XXXXXXXX, XXXXX. Gerresheimer acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Gerresheimer
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGerresheimer Investment Activity
Gerresheimer invested in XXX companies to date.
Gerresheimer made its latest investment on XXXXXXXX, XXXXX. Gerresheimer invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Gerresheimer
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Gerresheimer
| When was Gerresheimer founded? | Gerresheimer was founded in 1864. |
| Where is Gerresheimer headquartered? | Gerresheimer is headquartered in Germany. |
| How many employees does Gerresheimer have? | As of today, Gerresheimer has over 12K employees. |
| Is Gerresheimer publicly listed? | Yes, Gerresheimer is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Gerresheimer? | Gerresheimer trades under GXI ticker. |
| When did Gerresheimer go public? | Gerresheimer went public in 2007. |
| Who are competitors of Gerresheimer? | Gerresheimer main competitors are Salus, Embecta, Arjo, Cerus. |
| What is the current market cap of Gerresheimer? | Gerresheimer's current market cap is $644M. |
| What is the current revenue of Gerresheimer? | Gerresheimer's last 12 months revenue is $3B. |
| What is the current revenue growth of Gerresheimer? | Gerresheimer revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Gerresheimer? | Current revenue multiple of Gerresheimer is 1.1x. |
| Is Gerresheimer profitable? | Yes, Gerresheimer is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Gerresheimer? | Gerresheimer's last 12 months EBITDA is $483M. |
| What is Gerresheimer's EBITDA margin? | Gerresheimer's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Gerresheimer? | Current EBITDA multiple of Gerresheimer is 6.1x. |
| What is the current FCF of Gerresheimer? | Gerresheimer's last 12 months FCF is ($68M). |
| What is Gerresheimer's FCF margin? | Gerresheimer's last 12 months FCF margin is (3%). |
| What is the current EV/FCF multiple of Gerresheimer? | Current FCF multiple of Gerresheimer is (43.4x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.